Ardsley Advisory Partners’s Zimmer Biomet ZBH Stock Holding History

Ardsley Advisory Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,330	Closed	-$1.5M	–	194
2020 Q3	$1.5M	Buy	11,330 +6,180	+120%	+$807K	0.29%	47
2020 Q2	$597K	Buy	+5,150	New	+$593K	0.13%	75
2020 Q1	–	Sell	-4,120	Closed	-$599K	–	169
2019 Q4	$599K	Sell	4,120 -4,120	-50%	-$569K	0.1%	96
2019 Q3	$1.1M	Buy	8,240 +1,030	+14%	+$133K	0.25%	63
2019 Q2	$824K	Buy	+7,210	New	+$844K	0.13%	74
2018 Q4	–	Sell	-7,725	Closed	-$986K	–	161
2018 Q3	$986K	Buy	7,725 +2,575	+50%	+$306K	0.13%	70
2018 Q2	$557K	Buy	+5,150	New	+$561K	0.08%	102
2017 Q4	–	Sell	-113,300	Closed	-$12.9M	–	176
2017 Q3	$12.9M	Buy	113,300 +108,665	+2,344%	+$12.5M	1.71%	13
2017 Q2	$578K	Hold	4,635	–	–	0.09%	89
2017 Q1	$549K	Buy	4,635 +1,030	+29%	+$117K	0.09%	94
2016 Q4	$361K	Sell	3,605 -5,665	-61%	-$607K	0.06%	98
2016 Q3	$1.17M	Buy	9,270 +6,695	+260%	+$827K	0.19%	75
2016 Q2	$301K	Sell	2,575 -1,545	-38%	-$175K	0.05%	108
2016 Q1	$427K	Buy	+4,120	New	+$399K	0.07%	83
2015 Q2	–	Sell	-189,005	Closed	-$21.6M	–	239
2015 Q1	$21.6M	Sell	189,005 -32,960	-15%	-$3.76M	3%	4
2014 Q4	$24.4M	Sell	221,965 -26,780	-11%	-$2.82M	3.88%	3
2014 Q3	$24.3M	Buy	248,745 +243,595	+4,730%	+$24M	3.2%	5
2014 Q2	$519K	Buy	+5,150	New	+$502K	0.07%	150
2014 Q1	–	Sell	-2,575	Closed	-$233K	–	272
2013 Q4	$233K	Sell	2,575 -2,575	-50%	-$223K	0.03%	138
2013 Q3	$411K	Hold	5,150	–	–	0.08%	85
2013 Q2	$375K	Buy	+5,150	New	+$385K	0.08%	93

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Ardsley Advisory Partners's ZBH Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 11,330 shares — an estimated $1.5M sold.

Ardsley Advisory Partners first reported a position in ZBH in Q2 2013 and held it in 21 quarters. The position peaked at $24.4M in Q4 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

Ardsley Advisory Partners reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 11,330 Zimmer Biomet shares in Q4 2020, an estimated $1.5M.
Ardsley Advisory Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 21 quarters.
Ardsley Advisory Partners's Zimmer Biomet position peaked at $24.4M in Q4 2014.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.